News

X-ZELL hMX™ technology now available for research

Singapore, September 2021 – X-ZELL’s widely recognised high-gradient magnetic Cell Separator (hMX™) is now available to researchers worldwide. Previously exclusive to X-ZELL, the patented system is part of the company's single-cell diagnostics platform, which is...

X-ZELL launches new Imaging Technology unit

Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement with Finnish Artificial Intelligence (AI)...

X-ZELL announces strategic expansion in Europe

Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany.  Recently voted the second-most innovative health-tech start-up in the world1, X-ZELL has developed a powerful platform...

X-ZELL welcomes new Head of Clinical Development

Singapore, November 2020 – X-ZELL, a Singapore start-up specialising in early cancer detection, has announced the appointment of Claire Fives as the company’s new Head of Clinical Development. Fives recently served as Associate Director, Clinical Operations, at...

X-ZELL named second-most innovative health tech start-up in the world

Singapore, November 2020 – X-ZELL placed second in a virtual referendum to determine the world’s most innovative health technology start-up. Fellow Singaporean start-up, Plano, took home the overall win after an eight-week voting process. Organised by global analyst...

World-first cancer screening technology trialled in Singapore

Singapore, November 2020 – Two of Singapore’s leading hospitals and medical research centres, National University Hospital (NUH) and Singapore General Hospital (SGH), are trialling a new diagnostic test capable of detecting traces of early-stage prostate cancer in a...

X-ZELL facing three start-up competition finals in one week

Singapore, November 2020 – Singapore start-up X-ZELL has been nominated for the finals of three high-profile start-up competitions and accelerator programs, all taking place within the same week from 11-18 Nov 2020. World’s Most Innovative Health Tech Start-up...

X-ZELL closes oversubscribed Seed+ round

Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world's most innovative health technology start-ups[1], X-ZELL specialises in the...

X-ZELL selected for prestigious MedTech Innovator Accelerator program

Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation specialising in medical technology and digital health,...

X-ZELL
Next-generation cytology

© 2024 X-ZELL Biotech Pte. Ltd.

Find Us

XZELL HQ